Therapeutic Strategies for Lysosomal Storage Diseases by Targeting Glial Cells

Therapeutic Strategies for Lysosomal Storage Diseases by Targeting Glial Cells

Sabir Es-Said, Fdil Naima
Copyright: © 2024 |Pages: 13
DOI: 10.4018/978-1-6684-9675-6.ch018
OnDemand:
(Individual Chapters)
Available
$37.50
No Current Special Offers
TOTAL SAVINGS: $37.50

Abstract

Lysosomal storage disorders (LSDs) are a group of about 70 life-threatening conditions caused by genetic defects affecting lysosomal components. The underscoring molecular deficiency leads to widespread cellular dysfunction through most tissues in the body, including peripheral organs and the central nervous system (CNS). Clinical and experimental strategies encompassing enzyme replacement, gene and cell therapies, substrate reduction, and chemical chaperones are showing considerable potential in attenuating the peripheral pathology. Microglial and astrocyte activation is a hallmark of many LSDs that affect the CNS, which often precedes and predicts regions where eventual neuron loss will occur. However, the timing, intensity, and duration of neuroinflammation may ultimately dictate the impact on CNS homeostasis. For example, a transient inflammatory response following CNS insult/injury can be neuroprotective, as glial cells attempt to remove the insult and provide trophic support to neurons.
Chapter Preview
Top

The Lysosomal System: Functions And Uses

The lysosome is an organelle which can be spherical, ovoid, or sometimes tubular, and having a variable size between 0.1 and 2 μm, present in most plant and animal cells (Appelqvist et al., 2013). In humans, lysosomes are present in around a hundred copies in all cells of the body, except in red blood cells. Two distinct classes of proteins are present at the lysosome: a) acid hydrolases, approximately 50 in number, activated by the acidic pH between 4.5 and 5 at the lumen of the lysosome, b) membrane proteins, which are 25 in number (Mindell, 2012). These enzymes and proteins are all essential for the lysosome to perform its functions. These consist in particular of degrading macromolecules, polysaccharides, glycosaminoglycans and complex lipids into their elementary molecules respectively: amino acids, monosaccharides and free fatty acids. Lysosomal degradation products are transported outside the lysosome via specific transporters located in the lysosomal membrane (Saftig & Klumperman, 2009), or via vesicular membrane trafficking for reuse in biosynthetic pathways (Ruivo et al., 2009). (Figure 1).

Complete Chapter List

Search this Book:
Reset